Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»óºÎ ¹× Áߺοä°ü°á¼®ÀÇ Ä¡·á: Holmium: YAG Laser¸¦ ÀÌ¿ëÇÑ ¹Ý°­¼º ¿ä°ü°æÇϹ輮¼ú°ú ü¿ÜÃæ°ÝÆļ⼮¼úÀÇ ºñ±³ Treatment of Upper and Mid Ureter Stones: Comparison of Semirigid Ureteroscopic Lithotripsy with Holmium: YAG Laser and Shock Wave Lithotripsy

´ëÇѺñ´¢±â°úÇÐȸÁö 2007³â 48±Ç 2È£ p.171 ~ 175
±Ç¿ë¿í, ÀÌ»óÀÍ, Á¤ÅÂÀ¶,
¼Ò¼Ó »ó¼¼Á¤º¸
±Ç¿ë¿í ( Kwon Yong-Uk ) 
°üµ¿´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

ÀÌ»óÀÍ ( Lee Sang-Ik ) 
°üµ¿´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¤ÅÂÀ¶ ( Jeong Tae-Yoong ) 
°üµ¿´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: To compare the success rates, complications and cost effectiveness of extracorporeal shock wave lithotripsy(ESWL) and ureteroscopic lithotripsy(URS) using a Holmium: YAG laser to establish the more effective treatment for upper and mid ureter stones.

Materials & Methods: This retrospective study included 83 and 286 patients treated with URS and ESWL, respectively, for upper and mid ureter stones. URS was performed with a 7.5Fr semi-rigid ureterorenoscope and Holmium: YAG laser. ESWL was performed with Stonelith V.5 (PCK, Turkey). The stone sizes, success rates, postoperative complications and cost effectiveness were analyzed for each group.

Results: The overall success rates of the URS and ESWL were 97.6 and 82.5%, respectively. Success rates of URS were 98.4 and 95.2% when the stones were smaller and larger than 10mm, respectively. In the ESWL group, the success rates after the third session were 86.3 and 65.4% with stones smaller and larger than 10mm, respectively. The complication rates associated with URS and ESWL were 6 and 4.2%, respectively. The average cost of URS was lower than that of ESWL.

Conclusion: In our study, URS with Holmium: YAG laser was more efficacious than ESWL. Considering both the success rate and cost effectiveness, URS should remain the recommended first-line treatment for upper and mid ureter stones. (Korean J Urol 2007;48:171-175)

Å°¿öµå

Ureter stone;Extracorporeal shockwave lithotripsy;Ureteroscopy;Holmium

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS